Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Special C
- Development stage
- Phase 1
- Lead developer
- Bazelet Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Special C is a terpene-enriched, THC-free, CBD-dominant medical cannabis oil formulation developed by Bazelet Group. It is designed specifically for the treatment of behavioral and communication difficulties in children with autism spectrum disorder (ASD). The formulation leverages Bazelet's proprietary terpene-enrichment technology to enhance the therapeutic effects of cannabidiol (CBD) without the psychoactive effects of tetrahydrocannabinol (THC). Special C has been evaluated in a Phase 1 crossover pilot study and is undergoing further evaluation in a Phase 2 randomized, double-blind, placebo-controlled clinical trial led by Prof. Adi Aran at Shaare Zedek Medical Center in Israel.
- Brand names
- BCANN Special CSpecial C
- Other names
- BCANN Special C OilS.C. OilSpecial C Bcann OilSpecial C Oilשמן ספיישל סי
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Special C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Special C.